Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-04-13 | 2021-02-22 |
| Drug Identification Number | 02425165 | 02425165 |
| Brand name | AURO-GALANTAMINE ER | AURO-GALANTAMINE ER |
| Common or Proper name | Galantamine Hydrobromide | Galantamine Hydrobromide |
| Company Name | AURO PHARMA INC | AURO PHARMA INC |
| Ingredients | GALANTAMINE | GALANTAMINE |
| Strength(s) | 16MG | 16MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 30's | 30's |
| ATC code | N06DA | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2021-01-18 | 2021-01-18 |
| Estimated end date | 2021-04-15 | 2021-03-30 |
| Actual end date | 2021-03-26 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Replaceable with Auro-Galantamine ER 16mg Cap 100 Btl | Replaceable with Auro-Galantamine ER 16mg Cap 100 Btl |
| Health Canada comments |